Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Roch Houot; Philippe Gaulard; Robert Schreiber; Ira Mellman; Olivier Lambotte; Pierre G Coulie; Thierry Fest; Alan Korman; Ronald Levy; Margaret Shipp; Karin Tarte; Holbrook Kohrt; Aurélien Marabelle; Stephen Ansell; Hervé Watier; Andrea van Elsas; Arun Balakumaran; Frederick Arce Vargas; Sergio A Quezada; Gilles Salles; Daniel Olive

doi:10.1080/2162402X.2016.1186323

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Oncoimmunology. 2016 May 19;5(7):e1186323. doi: 10.1080/2162402X.2016.1186323. eCollection 2016 Jul.

Authors

Roch Houot¹, Philippe Gaulard², Robert Schreiber³, Ira Mellman⁴, Olivier Lambotte⁵, Pierre G Coulie⁶, Thierry Fest⁷, Alan Korman⁸, Ronald Levy⁹, Margaret Shipp¹⁰, Karin Tarte⁷, Holbrook Kohrt¹¹, Aurélien Marabelle¹², Stephen Ansell¹³, Hervé Watier¹⁴, Andrea van Elsas¹⁵, Arun Balakumaran¹⁶, Frederick Arce Vargas¹⁷, Sergio A Quezada¹⁷, Gilles Salles¹⁸, Daniel Olive¹⁹

Affiliations

¹ Department of Hematology, CHU de Rennes , Rennes, France.
² Department of Pathology, Inserm U955, Université Paris-Est, CHU Henri Mondor , Créteil, France.
³ Department of Pathology and Immunology, Washington University , St. Louis, MO, USA.
⁴ Genentech , South San Francisco, CA, USA.
⁵ Department of Clinical Immunology and Internal Medicine, Hospital Kremlin Bicêtre, Université Paris-Sud , Orsay, France.
⁶ de Duve Institute, Université Catholique de Louvain , Brussels, Belgium.
⁷ Inserm U917, CHU de Rennes , Rennes, France.
⁸ Bristol-Myers Squibb , CA, USA.
⁹ Stanford School of Medicine , Stanford, CA, USA.
¹⁰ Dana-Farber Cancer Institute , Boston, MA, USA.
¹¹ Department of Medicine, Stanford School of Medicine , Stanford, CA, USA.
¹² Gustave Roussy Cancer Campus , Villejuif, France.
¹³ Division of Hematology , Mayo Clinic, Rochester, MN, USA.
¹⁴ CHRU de Tours, Université François-Rabelais and CNRS, UMR7292 , Tours, France.
¹⁵ Aduro Biotech Europe , Oss, The Netherlands.
¹⁶ Clinical Research-Oncology , Merck & Co , Kenilworth, NJ, USA.
¹⁷ UCL Cancer Institute, University College of London , London, UK.
¹⁸ Department of Hematology, Université Claude Bernard, Hospices Civils de Lyon , INSERM 1052 , Lyon, France.
¹⁹ Inserm UMR 1068, Institut Paoli Calmettes, Aix Marseille Université , Marseille, France.

Abstract

In November 2015, the CALYM Carnot Institute held a 2-d workshop to discuss the current and future development of immunomodulatory antibodies for the treatment of lymphoma. Highlights from the workshop are presented in this article.

Keywords: Immunomodulation; immunotherapy; lymphoma; programmed cell death 1 ligand 1; programmed cell death 1 receptor.

Publication types

Research Support, Non-U.S. Gov't